ArticleMolecular therapy. Oncology2026

Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506.

Lesley Schuitmaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.